Pharmaceutical

Opinion: Do dementia villages actually work? We just do...

While promising in theory, it’s not clear dementia villages actually work.

The official definition of infertility now includes LGB...

Infertility has a new definition in the U.S. — one that could make a big differe...

Opinion: Insulin is increasingly affordable in the U.S....

Insulin prices have started to come down in the U.S. How can we ensure people ar...

STAT+: Roivant’s CEO is a star, but even a blockbuster ...

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other ...

Maternal Covid-19 vaccination offers infants immunity f...

Maternal Covid-19 vaccination offers infants immunity for up to six months, a ne...

STAT+: Results on Novartis prostate cancer therapy coul...

Results presented Monday could expand the use of a Novartis therapy for metastat...

STAT+: Data on AstraZeneca cancer drug allay safety con...

Questions about one of AstraZeneca’s key cancer drug candidates have been doggin...

STAT+: In lung cancer, J&J data amount to latest salvo ...

At the annual meeting of the European Society for Medical Oncology, J&J unveiled...

Johnson & Johnson antiviral pill for dengue shows early...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Roche buys Roivant bowel disease d...

Roche will pay $7.1 billion for Roivant's Telavant Holdings, picking up a promis...

STAT+: Massachusetts biotechs seek to piggyback on weig...

"Massachusetts companies are taking new approaches the big guys aren’t taking ye...

STAT+: A controversial new study examines traditional C...

"Now is the time to prove whether this is a fluke, or a reflection of true benef...

AstraZeneca, maker of FluMist, seeks to allow at-home a...

People eligible to use the only needle-free flu vaccine available in the United ...

CDC recommends rationing of RSV shot due to shortages

The CDC has recommended rationing an important monoclonal antibody product to pr...

STAT+: With an old approach but new energy, ADCs take c...

With an old approach but new energy, ADCs take center stage as promising cancer ...

Why AstraZeneca’s CEO is accusing British tabloids of ‘...

Want to stay on top of the science and politics driving biotech today? Sign up t...